concentration was 7-9 t 2-6 mmol/l (142-2 L46-8 mg/100 ml) (mean SD, n = 3871), range 4-4 to 20-2 mmol/l (79-2 L 363-6 mg/100 ml). In the four days before treatment with the Biostator the blood glucose concentration was 149j1 8-9 mmol/l (268-2 £160-2 mg/100 ml) (n-61) and the range 1-44 mmol/l (18-792 mg/100 ml).
After this period of relative stability it was much easier to control her diabetes with intravenous and then subcutaneous infusions of insulin, and she went home on 5 February 1982 taking her usual subcutaneous dose.
Comment
We have shown that the Biostator can be used on a general medical ward to control brittle diabetes in the short term. Major advantages for the patient were the abolition of hypoglycaemia and the freedom from fingerprick blood samples, which allowed regular sleep. The absence of hypoglycaemia may have contributed to the improved diabetic stability when conventional insulin infusions were restarted. This improvement was only temporary and by May 1982 there had been three further episodes of insulin resistance.
It was not possible to compare insulin dosages delivered by the Biostator with those by conventional means because of an intermittent leak on the poorly designed connector joining the infusion tubing to the infusion cannula and because we took no precautions to prevent adsorption of insulin to plastic. The 
Patients, methods, and results
We studied 106 outpatients with Crohn's disease (age range 18-72 (mean 41) years); diagnoses were based on conventional criteria. Height, weight, mid-arm circumference (MAC), and triceps skinfold thickness (TSF) were measured in the standard way.4 Mid-arm muscle circumference (MAMC) was calculated from the formula MAMC=MAC-0-314 TSF.9 Results were expressed as a percentage of ideal standards. 4 There was a strong positive correlation between weight and mid-arm circumference, both expressed as a percentage of the ideal standard (r= 0-872, p< 0-001, n= 106). Forty-eight patients were taking prednisolone, with 40 receiving long-term treatment with a mean daily dose of 8 mg. The correlation coefficient in this group between weight and mid-arm circumference was also strongly positive (r=0-889, p<0-001, n=48). Mid-arm circumference at the 90°O standard (26-4 cm in men, 25-7 cm in women) appeared useful as a reference point as all 39 patients whose mid-arm circumference was less than 90°h of the ideal were below ideal weight, including 21 patients who were more than 10% below ideal weight.
Seventy patients with Crohn's disease were then arbitrarily divided into those undernourished with mid-arm circumference less than 90% ideal and those well nourished with mid-arm circumference greater than 90% ideal. Weight, mid-arm muscle circumference, and laboratory variables were compared between these two groups and also with results obtained from patients with ulcerative colitis and healthy subjects. Serum albumin concentration (normal range 35-50 g/l) was measured by SMA plus autoanalyser, serum prealbumin concentration (normal range 200-500 mg/l) by radial immunodiffusion, and haemoglobin concentration by Coulter counter. Creatinine height index (normal range 1 0±0 1) was based on mean daily urine creatinine excretion estimated from two consecutive 24-hour urine collections. This index gave a measure of lean body mass.
For each variable studied the groups were well matched in terms of numbers, age, and sex. The site of Crohn's disease was classified as diffuse small bowel, ileocaecal, ileocolonic, colonic, or anorectal. There were more patients with diffuse small-bowel disease and fewer with colonic and anorectal disease in the undernourished group with Crohn's disease compared with the well-nourished group (x2= 10-622, p< 005 
Comment
Patients with Crohn's disease with a mid-arm circumference less than 90% of the ideal standard had appreciably reduced laboratory and anthropometric variables compared with well-nourished patients whose mid-arm circumference was greater than 90% of the ideal standard. The impaired nutrition probably reflects more extensive small-bowel disease. Well-nourished patients with Crohn's disease were in turn similar to the two control groups. There was no significant difference in steroid treatment between the two groups with Crohn's disease, so that any steroid effect would not invalidate the result.
Although mid-arm circumference has been mainly used for nutritional assessment among children,2 3 it has been used in adults to assess dietary treatment with favourable results.5 Mid-arm circumference is simple to measure, and we believe it is a useful measurement in identifying a group of patients with Crohn's disease who are at risk of malnutrition and would benefit from more detailed nutritional assessment. Screening for alcohol abuse in pregnancy
The fetal alcohol syndrome has been thought to be the main hazard of alcohol abuse in pregnancy. It occurs only in women who regularly consume more than 100 g alcohol daily, and such drinking is usually obvious. The possible consequences of more moderate alcohol consumption-such as second trimester abortion, low birth weight, and delayed achievement of developmental goals-have received less attentionl 2 and detection of these more moderate rates of consumption (30-80 g alcohol daily) is more difficult. Laboratory tests for the detection of excessive drinking have been undertaken almost exclusively in alcoholics or in male heavy drinkers and there are no data to show whether these tests are of value in detecting potentially harmful levels of alcohol consumption in pregnancy. We assessed the value of y-glutamyl transpeptidase and mean cell volume measurements in detecting potentially harmful rates of alcohol consumption during pregnancy. 
Patients, methods, and results
Alcohol consumption was assessed in 450 consecutive pregnant women attending the antenatal clinic at the West London Hospital. A questionnaire on prepregnancy drinking habits was filled in by the doctor at the booking clinic. The questionnaire has previously been validated at Charing Cross Hospital.3 The ful blood count and mean cell volume were estimated using a Coulter counter "S". y-Glutamyl transpeptidase activity was measured by the Szasz method4 on serum that had been separated within two hours of venepuncture and stored at -4'C. The questionnaire and measurement of mean cell volume and y-glutamyl transpeptidase activity were repeated in the second and third trimesters on random subsets of 100 women and on all women found to be drinking heavily in the first trimester. Women who had been taking more than 30 g of alcohol daily for more than 12 months were considered to be heavy drinkers.
Raised activities of y-glutamyl transpeptidase were found in 12 out of 16 heavy drinkers in the first trimester; none were taking any drugs. Six of these 16 women continued to drink heavily at the same rate during pregnancy, but in only one was the y-glutamyl transpeptidase activity persistently raised for the remainder of her pregnancy ( figure) . None of the 16 heavy drinkers had a raised mean cell volume (more than 100 fl) at any time during pregnancy, though six of the 16 had previously had a mean cell volume of more than 100 fl documented. There were no significant differences between the normal ranges for y-glutamyl transpeptidase activity in each trimester.
Comment
These findings show that mean cell volume is not a valuable measure of potentially harmful drinking during pregnancy and that y-glutamyl transpeptidase is only of limited value in the first trimester. The observation that six out of 16 heavy drinkers had previously had a mean cell volume of greater than 100 fl that returned to normal during pregnancy may be explained by the development of relative iron deficiency in the first trimester. Furthermore, the physiological rise in mean cell volume (4 fl) occurring during normal pregnancy means this marker is probably only of value in detecting alcohol abuse during the first trimester.
We found no significant difference between the mean activities of y-glutamyl transpeptidase in each of the three trimesters, but others have reported a slight drop as pregnancy progresses. There is evidence that y-glutamyl transpeptidase activities in pregnant women with viral hepatitis are lower in the second than in the first trimester and the rise in y-glutamyl transpeptidase activities is attenuated in patients with acute hepatitis who are taking oral contraceptive preparations.5 Thus the failure to detect raised activities of y-glutamyl transpeptidase in our patients who continued to drink in the latter stages of pregnancy may be due to hormonal factors. Both the mean cell volume and y-glutamyl transpeptidase activity may be affected by drinking patterns but these did not change in the women in our study who were heavy drinkers.
